Teva Pharmaceutical Industries (TEVA) Interest Coverage Ratio (2017 - 2025)

Teva Pharmaceutical Industries' Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 0.76 for Q4 2025.

• Quarterly Interest Coverage Ratio rose 5355.8% year-over-year to 0.76 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5.43 (up 3715.11% YoY) and the FY2025 annual result came in at 0.92, up 713.09% from the prior year.
• Interest Coverage Ratio was 0.76 for Q4 2025 at Teva Pharmaceutical Industries, up from 0.01 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.76 in Q4 2025 and bottomed at 0.31 in Q4 2022.
• A 5-year average of 0.14 and a median of 0.03 in 2021 frame the typical range for Interest Coverage Ratio.
• Annual changes were most pronounced in 2022 — Interest Coverage Ratio sank 1168.22% — and 2025, when it soared 5355.8%.
• Teva Pharmaceutical Industries' Interest Coverage Ratio stood at 0.03 in 2021, then sank by 1168.22% to 0.31 in 2022, then jumped by 182.11% to 0.25 in 2023, then plunged by 105.72% to 0.01 in 2024, then surged by 5355.8% to 0.76 in 2025.
• Business Quant data shows TEVA's Interest Coverage Ratio at 0.76 in Q4 2025, 0.01 in Q4 2024, and 0.25 in Q4 2023.